Nothing Special   »   [go: up one dir, main page]

DE69129623D1 - Behandlungsverfahren für therapiewiderstehende schizophrenie mit amperozide - Google Patents

Behandlungsverfahren für therapiewiderstehende schizophrenie mit amperozide

Info

Publication number
DE69129623D1
DE69129623D1 DE69129623T DE69129623T DE69129623D1 DE 69129623 D1 DE69129623 D1 DE 69129623D1 DE 69129623 T DE69129623 T DE 69129623T DE 69129623 T DE69129623 T DE 69129623T DE 69129623 D1 DE69129623 D1 DE 69129623D1
Authority
DE
Germany
Prior art keywords
therapy
amperocide
treatment procedure
resistant schizophrenia
schizophrenia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69129623T
Other languages
English (en)
Other versions
DE69129623T2 (de
Inventor
Anders Bjoerk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia and Upjohn AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn AB filed Critical Pharmacia and Upjohn AB
Application granted granted Critical
Publication of DE69129623D1 publication Critical patent/DE69129623D1/de
Publication of DE69129623T2 publication Critical patent/DE69129623T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69129623T 1990-03-01 1991-02-27 Behandlungsverfahren für therapiewiderstehende schizophrenie mit amperozide Expired - Fee Related DE69129623T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/487,547 US5013735A (en) 1990-03-01 1990-03-01 Method of treating therapy-resistant schizophrenia with amperozide (N-ethyl-4-(4',4'-bis(p-fluorophenyl)butyl)-1-piperazine-carboxamide
PCT/SE1991/000161 WO1991012805A1 (en) 1990-03-01 1991-02-27 Method of treating therapy-resistant schizophrenia with amperozide

Publications (2)

Publication Number Publication Date
DE69129623D1 true DE69129623D1 (de) 1998-07-23
DE69129623T2 DE69129623T2 (de) 1998-12-17

Family

ID=23936183

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69129623T Expired - Fee Related DE69129623T2 (de) 1990-03-01 1991-02-27 Behandlungsverfahren für therapiewiderstehende schizophrenie mit amperozide

Country Status (8)

Country Link
US (1) US5013735A (de)
EP (1) EP0517787B1 (de)
JP (1) JP3243514B2 (de)
AT (1) ATE167398T1 (de)
DE (1) DE69129623T2 (de)
DK (1) DK0517787T3 (de)
ES (1) ES2117008T3 (de)
WO (1) WO1991012805A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300422A (en) * 1991-12-04 1994-04-05 Case Western Reserve University Screening method for controlling agranulocytosis
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use
WO2008005368A2 (en) * 2006-06-30 2008-01-10 Abbott Laboratories Piperazines as p2x7 antagonists
US20080139573A1 (en) * 2006-12-08 2008-06-12 Copharm Treatment of resistant Schizophrenia and other CNS disorders
JP7321114B2 (ja) * 2019-04-26 2023-08-04 ユニ・チャーム株式会社 吸収性物品用の流動体の配置方法及び吸収性物品

Also Published As

Publication number Publication date
ATE167398T1 (de) 1998-07-15
WO1991012805A1 (en) 1991-09-05
DE69129623T2 (de) 1998-12-17
EP0517787A1 (de) 1992-12-16
JP3243514B2 (ja) 2002-01-07
ES2117008T3 (es) 1998-08-01
JPH05504957A (ja) 1993-07-29
DK0517787T3 (da) 1999-04-06
EP0517787B1 (de) 1998-06-17
US5013735A (en) 1991-05-07

Similar Documents

Publication Publication Date Title
ES2166381T3 (es) Tratamiento de enfermedades vasculares hiperproliferativas.
EP0758904A4 (de) Methoden und zusammensetzungen für die behandlung von glomerulonephritis und anderen entzündungen
DE69535498D1 (de) Verfahren zur behandlung vaskulärer kopfschmerzen
KR890701107A (ko) 알쯔하이머 병 치료용 화합물들
HU912359D0 (en) The use of flupirtine active agents for treating muscle-tension
ATE116550T1 (de) Behandlung von neoplastischen krankenheiten mit interleukin-10.
ATE137965T1 (de) Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege
NO960620D0 (no) Antipsykotisk fremgangsmåte
ATE137116T1 (de) Behandlung von entzündlichen erkrankungen mit 15- ketoprostaglandinen
DE69300321D1 (de) Behandlung neurodegenerativer Erkrankungen.
IT1224144B (it) Procedimento per il trattamento dei tessili
ATE53302T1 (de) Mittel zur behandlung von wunden.
DE69129623D1 (de) Behandlungsverfahren für therapiewiderstehende schizophrenie mit amperozide
DE3268024D1 (en) 0-alkyl-0-carbamoyl-glycero-phospho-cholines and process for their preparation
NO913117D0 (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
HUT36783A (en) Process for preparing 1,7-diphenyl-3-methyl-aza-7-cyano-8-methyl-nonane
IE811612L (en) Thiazoles
DE69307702D1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
ZA783512B (en) Process for the treatment of patients suffering from drepanocytosis
EA199800822A1 (ru) Способ лечения избыточной агрессии
ZA767652B (en) Process for the treatment of patients suffering from disorders induced by sludging
DE3373907D1 (en) N-acyl derivatives of dipeptides, their manufacture and use in treating diseases, and means therefor

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee